Diseases of the parathyroid gland in chronic kidney disease

@article{Komaba2011DiseasesOT,
  title={Diseases of the parathyroid gland in chronic kidney disease},
  author={Hirotaka Komaba and Takatoshi Kakuta and Masafumi Fukagawa},
  journal={Clinical and Experimental Nephrology},
  year={2011},
  volume={15},
  pages={797-809}
}
During the past few years, remarkable advances have been made in the understanding and the management of parathyroid diseases in patients with chronic kidney disease (CKD). One of the important insights is the identification of fibroblastic growth factor 23, which has greatly reshaped our understanding of secondary hyperparathyroidism (SHPT). The recent introduction of calcimimetic cinacalcet hydrochloride has led to a major breakthrough in the management of SHPT. Recognition of circulating… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism.

  • Scandinavian journal of clinical and laboratory investigation
  • 2017
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Hyperparathyroidism: an incidental finding.

  • The Nurse practitioner
  • 2012
VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.

  • Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
  • 2018
VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 162 REFERENCES

Regulation of fibroblast growth factor-23 signaling by klotho.

  • The Journal of biological chemistry
  • 2006
VIEW 15 EXCERPTS
HIGHLY INFLUENTIAL

EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.

  • Journal of the American Society of Nephrology : JASN
  • 2008
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism.

  • Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
  • 2011
VIEW 1 EXCERPT